Biochemistry, Genetics and Molecular Biology
Myeloid
100%
Stem Cell
44%
Enhancer Region
28%
LSD1
25%
Hematopoietic Stem Cell
23%
Transcription
16%
Proteomics
12%
Drug Resistance
12%
Cell Membrane Potential
11%
Progenitor Cell
10%
MicroRNA
10%
Forkhead Box C1
10%
GFI1
10%
Growth Factor
10%
Repressor
8%
Promoter Region
8%
P53
7%
Cellular Differentiation
7%
Transcription Factors
7%
Cancer Cell
6%
Ruxolitinib
6%
CD34
6%
Fusion Gene
6%
Demethylase
6%
Mouse Model
6%
Cell Proliferation
6%
Cancer Stem Cell
6%
Janus Kinase
5%
Serine
5%
Kinase
5%
Phosphotransferase
5%
Cell Survival
5%
Hematopoiesis
5%
Upregulation
5%
Glycogen Synthase Kinase 3
5%
Small Molecule
5%
Tyrosine Kinase Inhibitor
5%
Retinoblastoma
5%
Homeodomain
5%
Carcinogenesis
5%
Multigene Family
5%
Phosphatidylinositol
5%
Adult Stem Cell
5%
Corepressor
5%
IDH2
5%
Nilotinib
5%
FOXM1
5%
Bromodomain
5%
HDAC1
5%
P-Glycoprotein
5%
Medicine and Dentistry
Acute Myeloid Leukemia
70%
Stem Cell
28%
Diseases
22%
Leukemia
22%
Enhancer Region
21%
Leukemia Cell
20%
Hematopoietic Stem Cell
19%
Transcription Factors
16%
Myeloproliferative Neoplasm
14%
Myelofibrosis
12%
Chronic Myelomonocytic Leukemia
10%
Hematologic Malignancy
10%
Drug Resistance
10%
Janus Kinase
10%
Myeloid Leukemia
8%
Cancer Stem Cell
8%
Acute Lymphoblastic Leukemia
7%
Progenitor Cell
7%
Biological Product
7%
Histone Demethylase
7%
Ruxolitinib
7%
Acute Leukemia
6%
Chronic Myelogenous Leukemia
6%
Hematopoiesis
6%
Bone Marrow Transplantation
6%
Stem Cell
6%
Tranylcypromine Derivative
5%
Oncogene
5%
Leukemogenesis
5%
Cell Membrane Potential
5%
Cell Proliferation
5%
Fusion Protein
5%
Personalized Medicine
5%
Adenoviridae
5%
Multidrug Resistance Protein 1
5%
Adenovirus Infection
5%
Ecotropic Viral Integration Site-1
5%
Cohesin
5%
Non Melanoma Skin Cancer
5%
Prognostic Factor
5%
P21
5%
Adult Stem Cell
5%
Fulminant Hepatic Failure
5%
CCAAT Enhancer Binding Protein Alpha
5%
Functional Status
5%
Ponatinib
5%
Transcriptome
5%
Oncoprotein
5%
Phosphatidylinositol 4 Phosphate Kinase
5%
Serine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
60%
Malignant Neoplasm
21%
Myelofibrosis
21%
Disease
20%
Ruxolitinib
17%
Leukemia
15%
Histone Demethylase
15%
Lysine
14%
Hematologic Malignancy
12%
Glycogen Synthase Kinase 3
10%
Growth Factor
10%
Myeloproliferative Neoplasm
8%
Myeloid Leukemia
7%
Transcription Factors
7%
Mouse Model
7%
Protein P53
6%
Tranylcypromine Derivative
5%
Janus Kinase Inhibitor
5%
Symptom
5%
Bloodstream Infection
5%
Cohesin
5%
Biological Product
5%
Daunorubicin
5%
Navitoclax
5%
CCAAT Enhancer Binding Protein Alpha
5%
Leukemogenesis
5%
Non Melanoma Skin Cancer
5%
Acute Leukemia
5%
Isocitrate Dehydrogenase 1
5%
Isocitrate Dehydrogenase
5%
Drug Resistance
5%
Preclinical Study
5%
Functional Status
5%
Benzonitrile
5%
Janus Kinase
5%
Biological Marker
5%
